TIANJIN PHARMACN MEDICAL TECHNOLOGY CO., LTD. A high-tech driven enterprise, is dedicated to developing and manufacturing new drugs API and intermediates. It has R&D center, standardized experiment center, small GMP lab and pilot workshops, and two factories which are located in Tianjin Dagang Chemical Industrial Park and Jinghai Pharmaceutical Industrial Park ( with GMP standard).It passed ISO9001 certification in 2012. Tianjin Pharmacn holds more than 150 patents based on independent intelligence, focusing on the researching and developing of anti-Tumor, anti-diabetes and cardiovascular API and intermediates. The company has 50 sets of reactors from 100L to 5000L, with annual production capacity of 300MT, which can conduct -100 ~ 240 ℃ low and high temperature reactions, 0 ~ 5MPa catalytic reactions, and anhydrous oxygen free reactions. Besides of synthesis of Heterocyclic compounds,we also provide technical services of impurity tracking, stability analysis and composition of CTD files. With a experienced team of quality management, Tianjin Pharmacn has set up perfect quality standard system. And with this quality standard system, we can supervise and manage the overall process of enterprise risk evaluation, R&D, scale-up production, industrial production, analysis and sales services. And it assured our sustainable supply to customers with qualified products. Tianjin Pharmacn will continuously focus on API and intermediates field, and provide both domestic and oversea customers with perfect products and services.